Company news
Proteome Sciences Plc (LSE:PRM) news
Proteome Sciences Plc news releases on 6ix. Latest, Jul 1, 2019: Launch of new services powered by TMTpro 16plex
Press releases — page 2
Launch of new services powered by TMTpro 16plex
July 1, 2019
AGM Statement and Q1 Trading Update
April 30, 2019
Results and Notice of AGM
April 2, 2019
Block listing Interim Review
October 8, 2018
Loan Agreement and Notice of Results
July 3, 2018
Board Appointment
April 24, 2018
Block Admission return
April 3, 2018
GCLP Accreditation and Trading Update
October 18, 2017
Block Admission Return
October 3, 2017
Issue of Equity
September 1, 2017
Directorate Changes
August 1, 2017
Interim results for the 6 months to 30 June 2017
July 25, 2017
Stroke Diagnostic- Research Milestone Achieved
June 30, 2017
New Registered Address
June 12, 2017
AGM Statement and Result of AGM
April 25, 2017
Director Dealing and Total Voting Rights
April 11, 2017
Option Awards
April 4, 2017
Appointment of Richard Dennis as CCO
April 3, 2017
Preliminary Results
March 28, 2017
Trading Update & Notice of Results
February 9, 2017
Holdings in Company / PDMR Shareholding
January 4, 2017
Launch of new website
December 19, 2016
Result of GM and Completion of Placing
November 29, 2016
Director/PDMR Shareholding & Total Voting Rights
November 4, 2016
Placing and Subscription to raise £3.3 million
October 31, 2016
Publication: Journal of Alzheimer's disease
September 22, 2016
Half-year Report
September 15, 2016
Appointment of CEO
June 1, 2016
Publication of Annual Report
May 31, 2016
CEO Appointment
May 18, 2016
Deep Protein Profiling Key re. Cancer Treatment
April 5, 2016
Director Dealing
January 5, 2016
Clinical Trial Results for CK1d
November 5, 2015
Unaudited Interim Results
September 30, 2015
Change of Adviser
September 4, 2015
Placing to raise £2.5 million
June 23, 2015
Preliminary results
May 29, 2015
Blocklisting Interim Review
March 30, 2015
Trading Statement
March 9, 2015
Directorate Change
December 1, 2014
SysQuant - Update/Contract Awards
November 28, 2014
Half Yearly Report
September 30, 2014
CK1d Update: Toxicity Results
September 26, 2014
Contract with Genting TauRx Diagnostic Centre
September 25, 2014
Science and Technology Award
September 15, 2014
Appointment of Joint Broker
August 19, 2014
Alzheimer's blood test study
July 8, 2014
Annual Financial Report
June 9, 2014
Pancreatic Cancer Study in PLOS ONE
March 27, 2014
Placing
February 24, 2014